세계의 고강도 집속 초음파(HIFU) 시장 : 규모, 점유율, 동향 분석 보고서 - 용도별, 지역별 전망과 예측(2024-2031년)

Global High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Application, By Regional Outlook and Forecast, 2024 - 2031

US $ 3,600 ￦ 5,225,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,270,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,778,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

고강도 집속 초음파(HIFU) 시장 규모는 예측 기간 동안 7.1%의 연평균 복합 성장률(CAGR)로 시장 성장할 전망이며, 2031년까지 19억 달러에 달할 것으로 예상됩니다.

환자는 위험이 적고 회복 시간이 짧으며 침습성이 낮은 치료를 요구합니다. 전통적인 외과 수술은 절개, 마취 및 입원 기간의 연장을 수반하는 경우가 많으며 대부분 환자에게는 귀찮습니다. 대조적으로, HIFU는 절개하지 않고 초점을 맞춘 초음파를 사용하여 조직을 표적으로 하고 치료하는 비침습적인 대안을 제공합니다. 이 침습성이 낮은 치료 옵션의 매력으로 환자는 HIFU를 선호하고 채택이 증가하고 있습니다. 결론적으로 비침습적 치료에 대한 선호도가 시장 성장을 뒷받침하고 있습니다.

그러나 HIFU 장비는 고도로 기술적으로 발전하고 있기 때문에 초기 자본 비용이 높습니다. HIFU 시스템의 구매, 설치 및 설치에 드는 비용은 특히 소규모 의료 시설 및 개발 도상 지역의 의료 시설에서 엄청난 금액이 될 수 있습니다. 이 고액의 초기 투자는 건강 관리 제공업체가 HIFU 기술을 채택하는 것을 막을 수 있습니다. HIFU 장비의 유지보수를 위해서는 최적의 성능을 보장하기 위해 전문적인 서비스와 정기적인 업그레이드가 필요합니다. 이러한 지속적인 비용은 HIFU 시스템의 운영에 소요되는 총 비용에 추가됩니다. 결론적으로 장비와 절차의 고비용은 시장 성장을 방해합니다.

용도 전망

용도에 따라 시장은 자궁 근종, 전립선 암, 본태성 진전, 피부과, 유방암, 녹내장, 요통, 안면 형성 등으로 분류됩니다. 2023년에는 피부과 부문이 시장에서 20%의 수익 점유율을 획득했습니다. HIFU는 처짐이나 주름과 같은 일반적인 피부과의 고민에 대처하는 비 수술적 얼굴의 상승과 계약에 효과적입니다. 콜라겐 생성을 자극하고 피부 탄력과 회춘으로 이어지기 때문에 미용 피부과 시장에서 특히 매력적입니다.

최종 용도 전망

최종 용도별로 볼 때 시장은 병원, 영상 진단센터 등으로 나뉩니다. 이미징 센터 부문은 2023년 시장에서 33%의 수익 점유율을 획득했습니다. 영상 진단센터는 진단 영상과 개입 절차를 전문으로 하며, HIFU 실시에 적합합니다. 이 센터에서의 영상 진단에 대한 전문 지식과 중점은 HIFU 치료의 질을 향상시키고 정확한 타겟팅을 보장합니다. 영상 진단센터는 종종 환자에게 병원보다 접근하기 쉽고 편리한 장소입니다.

지역 전망

지역별로 보면 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카에 걸쳐 분석되고 있습니다. 북미는 2023년 시장에서 38%의 수익 점유율을 기록했습니다. 북미, 특히 미국과 캐나다에는 최첨단 의료 기술과 시설에 접근할 수 있는 잘 발달된 건강 관리 인프라가 있습니다. 이 인프라는 HIFU와 같은 고급 치료법의 채택과 사용을 지원합니다. 자궁근종, 전립선암, 특정 종양 등 HIFU로 치료할 수 있는 질병의 유병률은 북미에서는 비교적 높습니다. 이것은 효과적인 치료 옵션 수요를 촉진합니다.

목차

제1장 시장 범위 및 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요람

• 주요 하이라이트

제3장 시장 개요

• 서문
  • 개요
    • 시장구성 및 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 과제
• Porter's Five Forces 분석

제4장 세계 시장 : 최종 용도별

• 세계의 병원 시장 : 지역별
• 세계의 이미지 센터 시장 : 지역별
• 세계의 기타 시장 : 지역별

제5장 세계 시장 : 용도별

• 세계의 피부과 시장 : 지역별
• 세계의 자궁근종 시장 : 지역별
• 세계의 전립선암 시장 : 지역별
• 세계의 본태성 진전 시장 : 지역별
• 세계의 유방암 시장 : 지역별
• 세계의 녹내장 시장 : 지역별
• 세계의 요통, 관절통 유발성 질환 시장 : 지역별
• 세계의 기타 시장 : 지역별

제6장 세계 시장 : 지역별

• 북미
  • 북미 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 호주
    • 기타 아시아태평양
• 라틴아메리카, 중동 및 아프리카
  • 라틴아메리카, 중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카
    • 나이지리아
    • 기타 라틴아메리카, 중동 및 아프리카

제7장 기업 프로파일

• EDAP TMS SA
• Sonablate Corp
• Verasonics, Inc
• ALPINION MEDICAL SYSTEMS Co, Ltd.
• Theraclion
• Lynton Lasers Ltd
• ULTRAISER
• Profound Medical Corp

제8장 고강도 집속 초음파 시장에서의 성공 필수 조건

AJY

영문 목차

영문목차

The Global High Intensity Focused Ultrasound Market size is expected to reach $1.9 billion by 2031, rising at a market growth of 7.1% CAGR during the forecast period.

HIFU is a uterus-preserving procedure, which is important for patients who wish to retain their uterus for future pregnancies. This aspect of HIFU makes it a preferred option for women who want to avoid hysterectomy, which involves the removal of the uterus. Thus, the uterine fibroids segment attained 19% revenue share in the market in 2023. HIFU is typically performed as an outpatient, meaning patients do not need to stay overnight in a hospital. This convenience adds to its appeal and makes it a more accessible option for many.

Chronic diseases like cancer are becoming more prevalent worldwide, with increasing rates of prostate cancer, liver cancer, and other solid tumours. HIFU has been established as an effective non-invasive treatment option for certain types of cancer, such as prostate cancer, where it is used to destroy cancerous tissues without the need for surgery. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers. Hence, the increasing prevalence of chronic diseases drives the market's growth.

Patients increasingly seek less invasive treatments with fewer risks and shorter recovery times. Traditional surgical procedures often involve incisions, anaesthesia, and extended hospital stays, which can be daunting for many patients. In contrast, HIFU offers a non-invasive alternative using focused ultrasound waves to target and treat tissues without incisions. This appeal of a less invasive treatment option drives patient preference toward HIFU, increasing its adoption. In conclusion, the growing preference for non-invasive procedures propels the market's growth.

However, HIFU equipment is sophisticated and technologically advanced, which results in high initial capital costs. The expense of purchasing, installing, and setting up HIFU systems can be prohibitive, particularly for smaller healthcare facilities or those in developing regions. This high upfront investment can deter healthcare providers from adopting HIFU technology. The maintenance of HIFU equipment requires specialized service and regular upgrades to ensure optimal performance. These ongoing costs add to the total expenditure of operating HIFU systems. In conclusion, the high cost of equipment and procedures is hampering the market's growth.

Application Outlook

Based on application, the market is divided into uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, back pain, facetogenic, and others. In 2023, the dermatology segment garnered 20% revenue share in the market. HIFU is effective for non-surgical face lifting and tightening, which addresses common dermatological concerns such as sagging skin and wrinkles. It stimulates collagen production, leading to skin tightening and rejuvenation, which is particularly appealing in the cosmetic dermatology market.

End Use Outlook

By end use, the market is divided into hospitals, imaging centers, and others. The imaging centres segment procured 33% revenue share in the market in 2023. Imaging centres specialize in diagnostic imaging and interventional procedures, making them well-suited for performing HIFU. The expertise and focus on imaging in these centres enhance the quality of HIFU treatments and ensure accurate targeting. Imaging centres often provide a more accessible and convenient location for patients than hospitals.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 38% revenue share in the market in 2023. North America, particularly the United States and Canada, has a well-developed healthcare infrastructure with access to cutting-edge medical technologies and facilities. This infrastructure supports the adoption and use of advanced treatments like HIFU. The prevalence of conditions that HIFU can treat, such as uterine fibroids, prostate cancer, and certain types of tumours, is relatively high in North America. This drives the demand for effective treatment options.

List of Key Companies Profiled

• EDAP TMS S.A
• Sonablate Corp.
• Verasonics, Inc.
• ALPINION MEDICAL SYSTEMS Co., Ltd.
• Theraclion
• Lynton Lasers Ltd
• ULTRAISER
• PROFOUND MEDICAL CORP.

Global High Intensity Focused Ultrasound Market Report Segmentation

By End Use

• Hospital
• Imaging Centers
• Others

By Application

• Dermatology
• Uterine Fibroids
• Prostate Cancer
• Essential Tremor
• Breast Cancer
• Glaucoma
• Backpain, Facetogenic
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global High Intensity Focused Ultrasound Market, by End Use
  • 1.4.2 Global High Intensity Focused Ultrasound Market, by Application
  • 1.4.3 Global High Intensity Focused Ultrasound Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global High Intensity Focused Ultrasound Market by End Use

• 4.1 Global Hospital Market by Region
• 4.2 Global Imaging Centers Market by Region
• 4.3 Global Others Market by Region

Chapter 5. Global High Intensity Focused Ultrasound Market by Application

• 5.1 Global Dermatology Market by Region
• 5.2 Global Uterine Fibroids Market by Region
• 5.3 Global Prostate Cancer Market by Region
• 5.4 Global Essential Tremor Market by Region
• 5.5 Global Breast Cancer Market by Region
• 5.6 Global Glaucoma Market by Region
• 5.7 Global Backpain, Facetogenic Market by Region
• 5.8 Global Others Market by Region

Chapter 6. Global High Intensity Focused Ultrasound Market by Region

• 6.1 North America High Intensity Focused Ultrasound Market
  • 6.1.1 North America High Intensity Focused Ultrasound Market by End Use
    • 6.1.1.1 North America Hospital Market by Country
    • 6.1.1.2 North America Imaging Centers Market by Country
    • 6.1.1.3 North America Others Market by Country
  • 6.1.2 North America High Intensity Focused Ultrasound Market by Application
    • 6.1.2.1 North America Dermatology Market by Country
    • 6.1.2.2 North America Uterine Fibroids Market by Country
    • 6.1.2.3 North America Prostate Cancer Market by Country
    • 6.1.2.4 North America Essential Tremor Market by Country
    • 6.1.2.5 North America Breast Cancer Market by Country
    • 6.1.2.6 North America Glaucoma Market by Country
    • 6.1.2.7 North America Backpain, Facetogenic Market by Country
    • 6.1.2.8 North America Others Market by Country
  • 6.1.3 North America High Intensity Focused Ultrasound Market by Country
    • 6.1.3.1 US High Intensity Focused Ultrasound Market
      • 6.1.3.1.1 US High Intensity Focused Ultrasound Market by End Use
      • 6.1.3.1.2 US High Intensity Focused Ultrasound Market by Application
    • 6.1.3.2 Canada High Intensity Focused Ultrasound Market
      • 6.1.3.2.1 Canada High Intensity Focused Ultrasound Market by End Use
      • 6.1.3.2.2 Canada High Intensity Focused Ultrasound Market by Application
    • 6.1.3.3 Mexico High Intensity Focused Ultrasound Market
      • 6.1.3.3.1 Mexico High Intensity Focused Ultrasound Market by End Use
      • 6.1.3.3.2 Mexico High Intensity Focused Ultrasound Market by Application
    • 6.1.3.4 Rest of North America High Intensity Focused Ultrasound Market
      • 6.1.3.4.1 Rest of North America High Intensity Focused Ultrasound Market by End Use
      • 6.1.3.4.2 Rest of North America High Intensity Focused Ultrasound Market by Application
• 6.2 Europe High Intensity Focused Ultrasound Market
  • 6.2.1 Europe High Intensity Focused Ultrasound Market by End Use
    • 6.2.1.1 Europe Hospital Market by Country
    • 6.2.1.2 Europe Imaging Centers Market by Country
    • 6.2.1.3 Europe Others Market by Country
  • 6.2.2 Europe High Intensity Focused Ultrasound Market by Application
    • 6.2.2.1 Europe Dermatology Market by Country
    • 6.2.2.2 Europe Uterine Fibroids Market by Country
    • 6.2.2.3 Europe Prostate Cancer Market by Country
    • 6.2.2.4 Europe Essential Tremor Market by Country
    • 6.2.2.5 Europe Breast Cancer Market by Country
    • 6.2.2.6 Europe Glaucoma Market by Country
    • 6.2.2.7 Europe Backpain, Facetogenic Market by Country
    • 6.2.2.8 Europe Others Market by Country
  • 6.2.3 Europe High Intensity Focused Ultrasound Market by Country
    • 6.2.3.1 Germany High Intensity Focused Ultrasound Market
      • 6.2.3.1.1 Germany High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.1.2 Germany High Intensity Focused Ultrasound Market by Application
    • 6.2.3.2 UK High Intensity Focused Ultrasound Market
      • 6.2.3.2.1 UK High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.2.2 UK High Intensity Focused Ultrasound Market by Application
    • 6.2.3.3 France High Intensity Focused Ultrasound Market
      • 6.2.3.3.1 France High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.3.2 France High Intensity Focused Ultrasound Market by Application
    • 6.2.3.4 Russia High Intensity Focused Ultrasound Market
      • 6.2.3.4.1 Russia High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.4.2 Russia High Intensity Focused Ultrasound Market by Application
    • 6.2.3.5 Spain High Intensity Focused Ultrasound Market
      • 6.2.3.5.1 Spain High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.5.2 Spain High Intensity Focused Ultrasound Market by Application
    • 6.2.3.6 Italy High Intensity Focused Ultrasound Market
      • 6.2.3.6.1 Italy High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.6.2 Italy High Intensity Focused Ultrasound Market by Application
    • 6.2.3.7 Rest of Europe High Intensity Focused Ultrasound Market
      • 6.2.3.7.1 Rest of Europe High Intensity Focused Ultrasound Market by End Use
      • 6.2.3.7.2 Rest of Europe High Intensity Focused Ultrasound Market by Application
• 6.3 Asia Pacific High Intensity Focused Ultrasound Market
  • 6.3.1 Asia Pacific High Intensity Focused Ultrasound Market by End Use
    • 6.3.1.1 Asia Pacific Hospital Market by Country
    • 6.3.1.2 Asia Pacific Imaging Centers Market by Country
    • 6.3.1.3 Asia Pacific Others Market by Country
  • 6.3.2 Asia Pacific High Intensity Focused Ultrasound Market by Application
    • 6.3.2.1 Asia Pacific Dermatology Market by Country
    • 6.3.2.2 Asia Pacific Uterine Fibroids Market by Country
    • 6.3.2.3 Asia Pacific Prostate Cancer Market by Country
    • 6.3.2.4 Asia Pacific Essential Tremor Market by Country
    • 6.3.2.5 Asia Pacific Breast Cancer Market by Country
    • 6.3.2.6 Asia Pacific Glaucoma Market by Country
    • 6.3.2.7 Asia Pacific Backpain, Facetogenic Market by Country
    • 6.3.2.8 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific High Intensity Focused Ultrasound Market by Country
    • 6.3.3.1 China High Intensity Focused Ultrasound Market
      • 6.3.3.1.1 China High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.1.2 China High Intensity Focused Ultrasound Market by Application
    • 6.3.3.2 Japan High Intensity Focused Ultrasound Market
      • 6.3.3.2.1 Japan High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.2.2 Japan High Intensity Focused Ultrasound Market by Application
    • 6.3.3.3 India High Intensity Focused Ultrasound Market
      • 6.3.3.3.1 India High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.3.2 India High Intensity Focused Ultrasound Market by Application
    • 6.3.3.4 South Korea High Intensity Focused Ultrasound Market
      • 6.3.3.4.1 South Korea High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.4.2 South Korea High Intensity Focused Ultrasound Market by Application
    • 6.3.3.5 Singapore High Intensity Focused Ultrasound Market
      • 6.3.3.5.1 Singapore High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.5.2 Singapore High Intensity Focused Ultrasound Market by Application
    • 6.3.3.6 Australia High Intensity Focused Ultrasound Market
      • 6.3.3.6.1 Australia High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.6.2 Australia High Intensity Focused Ultrasound Market by Application
    • 6.3.3.7 Rest of Asia Pacific High Intensity Focused Ultrasound Market
      • 6.3.3.7.1 Rest of Asia Pacific High Intensity Focused Ultrasound Market by End Use
      • 6.3.3.7.2 Rest of Asia Pacific High Intensity Focused Ultrasound Market by Application
• 6.4 LAMEA High Intensity Focused Ultrasound Market
  • 6.4.1 LAMEA High Intensity Focused Ultrasound Market by End Use
    • 6.4.1.1 LAMEA Hospital Market by Country
    • 6.4.1.2 LAMEA Imaging Centers Market by Country
    • 6.4.1.3 LAMEA Others Market by Country
  • 6.4.2 LAMEA High Intensity Focused Ultrasound Market by Application
    • 6.4.2.1 LAMEA Dermatology Market by Country
    • 6.4.2.2 LAMEA Uterine Fibroids Market by Country
    • 6.4.2.3 LAMEA Prostate Cancer Market by Country
    • 6.4.2.4 LAMEA Essential Tremor Market by Country
    • 6.4.2.5 LAMEA Breast Cancer Market by Country
    • 6.4.2.6 LAMEA Glaucoma Market by Country
    • 6.4.2.7 LAMEA Backpain, Facetogenic Market by Country
    • 6.4.2.8 LAMEA Others Market by Country
  • 6.4.3 LAMEA High Intensity Focused Ultrasound Market by Country
    • 6.4.3.1 Brazil High Intensity Focused Ultrasound Market
      • 6.4.3.1.1 Brazil High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.1.2 Brazil High Intensity Focused Ultrasound Market by Application
    • 6.4.3.2 Argentina High Intensity Focused Ultrasound Market
      • 6.4.3.2.1 Argentina High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.2.2 Argentina High Intensity Focused Ultrasound Market by Application
    • 6.4.3.3 UAE High Intensity Focused Ultrasound Market
      • 6.4.3.3.1 UAE High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.3.2 UAE High Intensity Focused Ultrasound Market by Application
    • 6.4.3.4 Saudi Arabia High Intensity Focused Ultrasound Market
      • 6.4.3.4.1 Saudi Arabia High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.4.2 Saudi Arabia High Intensity Focused Ultrasound Market by Application
    • 6.4.3.5 South Africa High Intensity Focused Ultrasound Market
      • 6.4.3.5.1 South Africa High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.5.2 South Africa High Intensity Focused Ultrasound Market by Application
    • 6.4.3.6 Nigeria High Intensity Focused Ultrasound Market
      • 6.4.3.6.1 Nigeria High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.6.2 Nigeria High Intensity Focused Ultrasound Market by Application
    • 6.4.3.7 Rest of LAMEA High Intensity Focused Ultrasound Market
      • 6.4.3.7.1 Rest of LAMEA High Intensity Focused Ultrasound Market by End Use
      • 6.4.3.7.2 Rest of LAMEA High Intensity Focused Ultrasound Market by Application

Chapter 7. Company Profiles

• 7.1 EDAP TMS S.A
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expenses
• 7.2 Sonablate Corp.
  • 7.2.1 Company Overview
• 7.3 Verasonics, Inc.
  • 7.3.1 Company Overview
• 7.4 ALPINION MEDICAL SYSTEMS Co., Ltd.
  • 7.4.1 Company Overview
• 7.5 Theraclion
  • 7.5.1 Company Overview
• 7.6 Lynton Lasers Ltd
  • 7.6.1 Company Overview
• 7.7 ULTRAISER
  • 7.7.1 Company Overview
• 7.8 Profound Medical Corp.
  • 7.8.1 Company Overview
  • 7.8.2 Financial Analysis

Chapter 8. Winning Imperatives for High Intensity Focused Ultrasound Market

관련자료